413 related articles for article (PubMed ID: 12509844)
21. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
22. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
23. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
[TBL] [Abstract][Full Text] [Related]
25. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
26. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
Motomura M; Johnston I; Lang B; Vincent A; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):85-7. PubMed ID: 7823075
[TBL] [Abstract][Full Text] [Related]
27. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
28. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; De Haro L; Seagar M
J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
[TBL] [Abstract][Full Text] [Related]
30. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
31. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
[TBL] [Abstract][Full Text] [Related]
32. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Motomura M; Iwanaga H
Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
[TBL] [Abstract][Full Text] [Related]
33. Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels.
Motin L; Yasuda T; Schroeder CI; Lewis RJ; Adams DJ
Eur J Neurosci; 2007 Jan; 25(2):435-44. PubMed ID: 17284184
[TBL] [Abstract][Full Text] [Related]
34. [The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases].
Motomura M
Rinsho Shinkeigaku; 1999 Dec; 39(12):1237-9. PubMed ID: 10791087
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
[TBL] [Abstract][Full Text] [Related]
37. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
[TBL] [Abstract][Full Text] [Related]
38. Immunopathology of the Lambert-Eaton myasthenic syndrome.
Lang B; Newsom-Davis J
Springer Semin Immunopathol; 1995; 17(1):3-15. PubMed ID: 7482225
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.
Clouston PD; Saper CB; Arbizu T; Johnston I; Lang B; Newsom-Davis J; Posner JB
Neurology; 1992 Oct; 42(10):1944-50. PubMed ID: 1407577
[TBL] [Abstract][Full Text] [Related]
40. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]